Skip to main content
. 2016 Apr 4;171(2):821–832. doi: 10.1104/pp.15.01878

Figure 2.

Figure 2.

NAB1 can be nitrosylated in vitro. A, Analysis of NAB1 and GAPC1 in vitro glutathionylation following treatment with hydrogen peroxide (0.1 mm) and glutathione (0.5 mm) via MALDI-TOF mass spectrometry. Left panel: Mass spectrum of GAPC1 obtained after treatment with GSH+H2O2 and subsequent reduction using DTT (2.5 mm; used as a control). A mass increase of 305 D corresponds to one glutathione molecule covalently bound per protein monomer. The peaks labeled “matrix adducts” correspond to proteins with a sinapinic acid adduct. Differences between mass peaks of unmodified NAB1 and GAPC1 are within the experimental error of the instrument. Right panel: Mass spectrometric analysis of recombinant NAB1 under identical conditions. B, Treatment of recombinant NAB1 (wt) and NAB1C226S (C226S) with the NO-donor DEA-NONOate followed by the biotin switch technique. Addition (+) or omission (−) of the reaction components DEA-NONOate (1 mm), ascorbate (ASC; 40 mm), and DTT (20 mm) during the assay is indicated in the upper part. NAB1-biotinylation as an indicator for prior nitrosylation was detected by immunoblotting with a biotin-specific antiserum (αbiotin), and NAB1 protein amounts were assessed by Coomassie staining (CBB) after SDS-PAGE separation.